TheFiscalFinder
● Single award · contract

Production of Therapeutic in Support of National Emergency Response to Coronavirus 2019 (COVID-19): IN…

A single federal award, with both ends of the trail linked.
$5.6B
total award value
2021
action date
18 mo
period
W15QKN21C0014
PIID
Agency ›
Department of Defense
✓ from source
awarded→$5.6B
Recipient ›
Regeneron Pharmaceuticals Inc
✓ from source
performed in→
State ›
New York
✓ from source

Description

Production of Therapeutic in Support of National Emergency Response to Coronavirus 2019 (COVID-19): IN Support of Operation Warp Speed (Ows), the Government Is Purchasing Up to 1,250,000 Doses of the Emergency Use Authorization (Eua) Therapeutic.

Awarding agencyDepartment of Defense →
RecipientRegeneron Pharmaceuticals Inc →
Place of performanceNew York →
CategoryNAICS 325414PSC 6505
Competed?Not recorded✓ from source
Total (exact)$5,565,000,000

More awards to Regeneron Pharmaceuticals Inc

Contract HHSO100201700016C
awarded 2017$693.1M
Regeneron Other Transaction Authority (Ota) Award
awarded 2017$279.6M
All awards to this recipient →

More from Department of Defense

Contract HT940216C0001
awarded 2016$51.3B
LRIP Lot 12 Advance Acquisition Contract
awarded 2017$35.1B
SSN 802 and 803 Long Lead Time Material
awarded 2017$34.9B
Contract N0001902C3002
awarded 2001$34.2B
KC-X Modernization Program
awarded 2011$32B
All awards from this agency →
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.